Malignant Brain Neoplasm clinical trials
28 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
- CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children
- Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
- Feasibility of FMISO in Brain Tumors
- 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
- Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
- Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
- Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
- Cancer Genetic Testing in Ethnic Populations
- F-Tryptophan PET/CT in Human Cancers
- Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- Intravital Microscopy in Human Solid Tumors
- Wearable Devices and Biomarkers Project (Healthiomics)
- Ultra-Low Field (ULF) Point-of-Care (POC) MRI System for Brain Morphology and Pathology
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- NeuroPathways Intervention for Brain Tumor Patients
- ASCENT Intervention for Brain Tumor Patients
- Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy
- Digital Art Therapy for Young Cancer Survivors
- HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
- Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
- Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer
- Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review
- Quest to Analyze One Thousand Humans Meditating
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Malignant Brain Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.